Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival von Anderson, Nathaniel D., Babichev, Yael, Fuligni, Fabio, Comitani, Federico, Layeghifard, Mehdi, Venier, Rosemarie E., Dentro, Stefan C., Maheshwari, Anant, Guram, Sheena, Wunker, Claire, Thompson, J. Drew, Yuki, Kyoko E., Hou, Huayun, Zatzman, Matthew, Light, Nicholas, Bernardini, Marcus Q., Wunder, Jay S., Andrulis, Irene L., Ferguson, Peter, Razak, Albiruni R. Abdul, Swallow, Carol J., Dowling, James J., Al-Awar, Rima S., Marcellus, Richard, Rouzbahman, Marjan, Gerstung, Moritz, Durocher, Daniel, Alexandrov, Ludmil B., Dickson, Brendan C., Gladdy, Rebecca A., Shlien, Adam

Volltext

Miglustat as a therapeutic agent: prospects and caveats von Venier, Rosemarie E, Igdoura, Suleiman A

Volltext

Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance von Nakano, Yoshiko, Acker, Meryl, Druker, Harriet, van Engelen, Kalene, Meyn, M. Stephen, Wasserman, Jonathan D., Venier, Rosemarie E., Goudie, Catherine, Stosic, Ana, Huang, Annie, Greer, Mary-Louise C., Malkin, David, Villani, Anita, Gallinger, Bailey

Volltext

Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States von Venier, Rosemarie E., Grubs, Robin E., Kessler, Elena, Cooper, Kristine L., Bailey, Kelly M., Meade, Julia

Volltext

The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations von Villani, Anita, Davidson, Scott, Kanwar, Nisha, Lo, Winnie W, Li, Yisu, Cohen-Gogo, Sarah, Fuligni, Fabio, Edward, Lisa-Monique, Light, Nicholas, Layeghifard, Mehdi, Harripaul, Ricardo, Waldman, Larissa, Gallinger, Bailey, Comitani, Federico, Brunga, Ledia, Hayes, Reid, Anderson, Nathaniel D, Ramani, Arun K, Yuki, Kyoko E, Blay, Sasha, Johnstone, Brittney, Inglese, Cara, Hammad, Rawan, Goudie, Catherine, Shuen, Andrew, Wasserman, Jonathan D, Venier, Rosemarie E, Eliou, Marianne, Lorenti, Miranda, Ryan, Carol Ann, Braga, Michael, Gloven-Brown, Meagan, Han, Jianan, Montero, Maria, Spatare, Famida, Whitlock, James A, Scherer, Stephen W, Chun, Kathy, Somerville, Martin J, Hawkins, Cynthia, Abdelhaleem, Mohamed, Ramaswamy, Vijay, Somers, Gino R, Kyriakopoulou, Lianna, Hitzler, Johann, Shago, Mary, Morgenstern, Daniel A, Tabori, Uri, Meyn, Stephen, Irwin, Meredith S, Malkin, David, Shlien, Adam

Volltext

A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counseling von Venier, Rosemarie E., Maurer, Lisa M., Kessler, Elena M., Ranganathan, Sarangarajan, McGough, Richard L., Weiss, Kurt R., Malek, Marcus M., Meade, Julia, Tersak, Jean M., Bailey, Kelly M.

Volltext

Neuronal pentraxin 1 depletion delays neurodegeneration and extends life in Sandhoff disease mice von Hooper, Alexander W M, Alamilla, Javier F, Venier, Rosemarie E, Gillespie, Deda C, Igdoura, Suleiman A

Volltext

BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma von Maurer, Lisa M, Daley, Jessica D, Mukherjee, Elina, Venier, Rosemarie E, Julian, Claire M, Bailey, Nathanael G, Jacobs, Michelle F, Kumar-Sinha, Chandan, Raphael, Haley, Periyapatna, Nivitha, Weiss, Kurt, Janeway, Katherine A, Mody, Rajen, Lucas, Peter C, McAllister-Lucas, Linda M, Bailey, Kelly M

Volltext

Abstract B014: Metabolic reprogramming in high-grade sarcomas: repurposing anti-cholesterol agents as a novel therapeutic strategy von Dorsey, Jen, Babichev, Yael, Venier, Rosemarie E., Marcellus, Richard, Al-awar, Rima, Penn, Linda Z., Razak, Albiruni A., Dickson, Brendan C., Chen, Eric, Andrulis, Irene L., Wunder, Jay, Gladdy, Rebecca A.

Volltext

A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counseling von Venier, Rosemarie E, Maurer, Lisa M, Kessler, Elena M, Ranganathan, Sarangarajan, McGough, Richard L, Weiss, Kurt R, Malek, Marcus M, Meade, Julia, Tersak, Jean M, Bailey, Kelly M

Volltext

Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma von McKinnon, Timothy, Venier, Rosemarie, Yohe, Marielle, Sindiri, Sivasish, Gryder, Berkley E., Shern, Jack F., Kabaroff, Leah, Dickson, Brendan, Schleicher, Krista, Chouinard-Pelletier, Guillaume, Menezes, Serena, Gupta, Abha, Zhang, Xiaohu, Guha, Rajarashi, Ferrer, Marc, Thomas, Craig J., Wei, Yuhong, Davani, Dariush, Guidos, Cynthia J., Khan, Javed, Gladdy, Rebecca A.

Volltext

Abstract B06: Targeting PI3K/mTOR in mouse rhabdomyosarcoma models driven by FGFR4 activation von McKinnon, Timothy, Venier, Rosemarie, Yohe, Marielle, Gryder, Berkley E., Dickson, Brendan, Schleicher, Krista, Davani, Dariush, Wei, Winnie, Guidos, Cynthia, Gupta, Abha, Khan, Javed, Gladdy, Rebecca

Volltext

Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation von McKinnon, Timothy, Venier, Rosemarie, Dickson, Brendan C, Kabaroff, Leah, Alkema, Manon, Chen, Li, Shern, Jack F, Yohe, Marielle E, Khan, Javed, Gladdy, Rebecca A

Volltext